ProBio Enters Exclusive Global Licensing Agreement with AbTis to Develop Next-Generation ADC Asset
Agreement expands collaboration between ProBio's biologics discovery capabilities and AbTis' site-specific antibody-drug conjugate technology HOPEWELL, N.J., Nov. 10, 2026 /PRNewswire/ -- ProBio, a global contract research, development, and manufacturing organization (CRDMO), today...